Sirius Investors

GCTK Stock: GlucoTrack, Inc. Stock Price, Analysis & Insights

Get live gctk stock price $10.59, comprehensive GlucoTrack, Inc. stock analysis, charts, news, and expert forecast. Real-time gctk stock data and investment insights.

10.59
117.45%Today
GCTKGlucoTrack, Inc. • NASDAQ Capital Market • Healthcare
Market Cap
6.01M
Volume
70.12M
52W High
3576.00
52W Low
4.22

Company Overview

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Company Information

CEO
Paul V. Goode
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
11

Contact Information

Address
8 Ariel Sharon Street
Country
IL

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 6.01M market capitalization
  • Trading Volume: 70.12M shares traded today
  • Price Range: 52-week range of $4.22 - $3576.00
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:N/A
EPS:$-2441.21
Beta:-0.18
Avg Volume:2.19M

Market Analysis for GlucoTrack, Inc.

GlucoTrack, Inc. (GCTK) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 6.01M, the company represents a significant player in its market. The stock is currently trading at $10.59 with a positivedaily change of 117.45%.

The company's 11 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of N/A, beta of -0.18, and 52-week price range from $4.22 to $3576.00when evaluating investment opportunities.

Why Invest in GlucoTrack, Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under Paul V. Goode
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.